Beam Therapeutics Inc (BEAM)

11:22 AM

BEAM SEC FilingsBeam Therapeutics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

11:22 AM

Apr 04, 2026

Beam Therapeutics Inc. (BEAM) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 04, 2026

Apr 04, 2026

SG Americas Securities LLC Boosts Beam Therapeutics Stake by 139% - National Today

Apr 04, 2026

Apr 04, 2026

SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM - MarketBeat

Apr 04, 2026

Apr 03, 2026

Beam Therapeutics Inc. (BEAM) stock price, news, quote and history - Yahoo Finance Australia

Apr 03, 2026

Apr 03, 2026

Intellia Therapeutics, Inc. (NTLA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

Beam Therapeutics Inc. (BEAM) interactive stock chart - Yahoo Finance Singapore

Apr 03, 2026

Apr 02, 2026

Beam Therapeutics (NASDAQ: BEAM) awards 20,000 RSUs to Chief Legal Officer - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM) awards 20,000 RSUs to SVP Bethany Cavanagh - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM) awards 31,750 RSUs to Chief Medical Officer Amy Simon - Stock Titan

Apr 02, 2026

Apr 02, 2026

CFO of Beam Therapeutics (NASDAQ: BEAM) awarded 31,750 RSUs - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM) grants president 40,000 restricted stock units - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM): Among the stocks that could 10x over the next 5 years - msn.com

Apr 02, 2026

Apr 02, 2026

Insider Selling: Beam Therapeutics (NASDAQ:BEAM) CEO Sells 25,000 Shares of Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM): Among the Stocks That Could 10x Over the Next 5 Years - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics Insider Sold Shares Worth $1,128,315, According to a Recent SEC Filing - Moomoo

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics shares climb after positive BEAM-302 trial update - MSN

Apr 02, 2026

Apr 02, 2026

BEAM.O Technical Analysis & Stock Price Forecast - intellectia.ai

Apr 02, 2026

Apr 02, 2026

Beam (BEAM) Reports Promising Data from BEACON Trial in Sickle C - GuruFocus

Apr 02, 2026

Apr 01, 2026

Beam Therapeutics publishes sickle cell therapy trial data By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Why Is BEAM Stock Edging Higher After Hours Today? - Stocktwits

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics CEO Evans sells $1.1m in stock By Investing.com - in.investing.com

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics CEO Evans sells $1.1m in stock - Investing.com

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics (BEAM) CEO sells 50K shares, gains 90K RSUs - Stock Titan

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine - The Manila Times

Apr 01, 2026

Apr 01, 2026

In 31 sickle cell patients, Beam saw no severe pain crises after risto-cel - Stock Titan

Apr 01, 2026

Mar 31, 2026

[144] Beam Therapeutics Inc. SEC Filing - Stock Titan

Mar 31, 2026

Mar 31, 2026

ETRADE Financial (NASDAQ: BEAM) insider sales and restricted vesting - Stock Titan

Mar 31, 2026

Mar 31, 2026

BEAM (NASDAQ: BEAM) affiliate notifies sale of 25,000 shares via option exercise - Stock Titan

Mar 31, 2026

Mar 31, 2026

Beam to advance gene-editing drug to pivotal development - MSN

Mar 31, 2026

Mar 30, 2026

BEAM (NASDAQ: BEAM) insider schedules 25,000-share sale after option exercise - Stock Titan

Mar 30, 2026

Mar 29, 2026

Beam Therapeutics gains on clinical update as gene therapy hits protective protein levels - MSN

Mar 29, 2026

Mar 28, 2026

(BEAM) Risk Channels and Responsive Allocation - Stock Traders Daily

Mar 28, 2026

Mar 28, 2026

JPMorgan Chase & Co. Has $13.14 Million Stock Position in Beam Therapeutics Inc. $BEAM - MarketBeat

Mar 28, 2026

Mar 28, 2026

Risk Recap: Is Beam Therapeutics Inc a cyclical or defensive stock2026 Levels & Long-Term Growth Plans - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

BEAM Stock's Gains Fade Despite Promising Data Rare Liver Disease Treatment Data - Stocktwits

Mar 27, 2026

Mar 27, 2026

Beam Therapeutics Inc. (BEAM) Discusses Topline Phase I/II Data for BEAM-302 in Alpha-1 Antitrypsin DeficiencySlideshow (NASDAQ:BEAM) 2026-03-27 - Seeking Alpha

Mar 27, 2026

Mar 27, 2026

Beam Therapeutics (NASDAQ:BEAM) Price Targets Rise As Nasdaq Futures Move - Kalkine Media

Mar 27, 2026

Mar 27, 2026

How The Investment Story For Beam Therapeutics (BEAM) Is Quietly Shifting With New Data And Funding - Yahoo Finance

Mar 27, 2026

Mar 27, 2026

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), KalVista Pharmaceuticals (KALV) and Ionis Pharmaceuticals (IONS) - The Globe and Mail

Mar 27, 2026

Mar 27, 2026

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), Maze Therapeutics, Inc. (MAZE) and Daiichi Sankyo Company (OtherDSKYF) - The Globe and Mail

Mar 27, 2026

Mar 26, 2026

Vanguard disaggregates holdings; reports 0% in Beam Therapeutics (NASDAQ: BEAM) - Stock Titan

Mar 26, 2026

Mar 26, 2026

Beam Therapeutics Gains On Clinical Update As Gene Therapy Hits Protective Protein Levels - Sahm

Mar 26, 2026

Mar 26, 2026

Beam Therapeutics (NASDAQ:BEAM) Trading 5.5% Higher on Analyst Upgrade - MarketBeat

Mar 26, 2026

Mar 26, 2026

Analysts’ Top Healthcare Picks: Alpha Teknova (TKNO), Beam Therapeutics (BEAM) - The Globe and Mail

Mar 26, 2026

Mar 26, 2026

BEAM Eyes Global Expansion of AATD Study After Strong Early Data - The Globe and Mail

Mar 26, 2026

Mar 26, 2026

BEAM Stock Sees Price Target Raised by Citigroup Analyst | BEAM - GuruFocus

Mar 26, 2026

Mar 26, 2026

Beam Therapeutics (NASDAQ:BEAM) Price Target Raised to $68.00 at Citigroup - MarketBeat

Mar 26, 2026

Mar 26, 2026

Beam Therapeutics stock holds at Outperform on AATD data - Investing.com UK

Mar 26, 2026

Mar 26, 2026

Beam Therapeutics stock holds at Outperform on AATD data By Investing.com - in.investing.com

Mar 26, 2026